drugset / Trial / NCT03875378
Transdermal Estrogen in Women With Anorexia Nervosa
Phase 2
Recruiting
66 enrolled
Pouneh K. Fazeli, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.
Timeline
- Start
- 2020-08-28
- Primary completion
- 2028-08-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.045 mg | Other |
| Subject | Levonorgestrel | Small molecule | 0.015 mg | Other |